膳食ω多不饱和脂肪酸摄入与系统性红斑狼疮患者报告结局的关联
基于密歇根狼疮流行病学与监测队列456例SLE患者,采用 Diet History Questionnaire II 估算n-3和n-6摄入,多变量回归调整年龄、性别、种族和BMI后发现,n-6:n-3比值每增加1单位,SLAQ评分平均高0.3分(95%CI 0.1,0.6;P=0.013);n-3每增加1克/1000千卡,SLAQ评分β=-0.8(95%CI -1.6,0.0;P=0.055),PROMIS睡眠障碍β=-1.1(95%CI -2.0,-0.2;P=0.017)。
要点
- n-6:n-3比值每增1单位,SLAQ评分高0.3分(95%CI 0.1,0.6;P=0.013)
- n-3每增1克/1000千卡,PROMIS睡眠障碍评分降1.1分(95%CI -2.0,-0.2;P=0.017)
- n-3每增1克/1000千卡,SLAQ评分β=-0.8(95%CI -1.6,0.0;P=0.055)
核心结论
- 较高膳食n-3脂肪酸摄入和较低n-6:n-3比值与SLE患者报告结局(尤其自我报告的狼疮活动和睡眠质量)呈有利关联。
研究设计与样本
- 基于人群的密歇根狼疮流行病学与监测队列,共456例SLE患者,采用Diet History Questionnaire II估算过去一年n-3和n-6摄入,多变量回归调整年龄、性别、种族和BMI。
主要发现
- 456例中425例(93.2%)为女性,207例(45.4%)为非裔美国人,平均±SD年龄52.9±12.3岁。
- n-6:n-3比值每增加1单位,平均SLAQ评分显著高0.3分(95%CI 0.1,0.6;P=0.013)。
- n-3每增加1克/1000千卡,SLAQ评分β=-0.8(95%CI -1.6,0.0;P=0.055),PROMIS睡眠障碍评分β=-1.1(95%CI -2.0,-0.2;P=0.017)。
- 较高n-3摄入与较低抑郁症状和合并纤维肌痛、较高生活质量呈非显著关联,n-6:n-3比值结果趋势相反。
临床怎么用
- 对SLE患者进行膳食评估时,可关注n-3摄入及n-6:n-3比值,作为患者报告结局相关的可干预饮食因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine associations between dietary intake of omega-3 (n-3; generally antiinflammatory) and omega-6 (n-6; generally proinflammatory) fatty acids and patient-reported outcomes in systemic lupus erythematosus (SLE). METHODS: This study was based on the population-based Michigan Lupus Epidemiology and Surveillance cohort. Estimates of n-3 and n-6 intake were derived from Diet History Questionnaire II items (past year with portion size version). Patient-reported outcomes included self-reported lupus activity (Systemic Lupus Activity Questionnaire [SLAQ]). Multivariable regression, adjusted for age, sex, race, and body mass index, was used to assess associations between absolute intake of n-3 and n-6, as well as the n-6:n-3 ratio, and patient-reported outcomes. RESULTS: Among 456 SLE cases, 425 (93.2%) were female, 207 (45.4%) were African American, and the mean ± SD age was 52.9 ± 12.3 years. Controlling for potential confounders, the average SLAQ score was significantly higher by 0.3 points (95% confidence interval [95% CI] 0.1, 0.6; P = 0.013) with each unit increase of the n-6:n-3 ratio. Both lupus activity and Patient-Reported Outcomes Measurement Information System (PROMIS) sleep disturbance scores were lower with each 1-gram/1,000 kcal increase of n-3 fatty acids (SLAQ regression coefficient β = -0.8 [95% CI -1.6, 0.0]; P = 0.055; PROMIS sleep β = -1.1 [95% CI -2.0, -0.2]; P = 0.017). Higher n-3 intakes were nonsignificantly associated with lower levels of depressive symptoms and comorbid fibromyalgia, and with higher quality of life, whereas results for the n6:n3 ratio trended in the opposite direction. CONCLUSION: This population-based study suggests that higher dietary intake of n-3 fatty acids and lower n-6:n-3 ratios are favorably associated with patient-reported outcomes in SLE, particularly self-reported lupus activity and sleep quality.
引用
- Charoenwoodhipong P, Harlow SD, Marder W, et al. Dietary Omega Polyunsaturated Fatty Acid Intake and Patient-Reported Outcomes in Systemic Lupus Erythematosus: The Michigan Lupus Epidemiology and Surveillance Program. Arthritis Care Res (Hoboken). 2020. PMID: 31074595. doi:10.1002/acr.23925
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。